A computational approach to unraveling TLR signaling in murine mammary carcinoma

We developed an agent-based model to simulate a signaling cascade which allowed us to focus on the behavior of each class of agents independently of the other classes except when they were in physical contact. A critical piece was the ratio of the populations of agents that interact with one another, not their absolute values. This ratio reflects the effects of the density of each agent in the biological cascade as well as their size and velocity. Although the system can be used for any signaling cascade in any cell type, to validate the system we modeled Toll-like receptor (TLR) signaling in two very different types of cells; tumor cells and white blood cells. The iterative process of using experimental data to improve a computational model, and using predictions from the model to design additional experiments strengthened our understanding of how TLR signaling differs between normal white blood cells and tumor cells. The model and experimental data showed that some of the differences between the tumor cells and normal white blood cells were related to NFκB and TAB3 levels, and also suggested that tumor cells lacked IRAKM-dependent feedback inhibition as a negative regulator of TLR signaling. Finally, we found that these different cell types had distinctly different responses when exposed to two signals indicating that a more biologically relevant model and experimental system should address activation of multiple interconnected signaling cascades, the complexity of which further reinforces the need for a combined computational and molecular approach.

[1]  H. Saji,et al.  Significant correlation of monocyte chemoattractant protein‐1 expression with neovascularization and progression of breast carcinoma , 2001, Cancer.

[2]  L. Hefler,et al.  Monocyte Chemoattractant Protein-1 Serum Levels in Patients with Breast Cancer , 2004, Tumor Biology.

[3]  Eric Bonabeau,et al.  Agent-based modeling: Methods and techniques for simulating human systems , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Kurt,et al.  Murine mammary carcinoma cells and CD11c(+) dendritic cells elicit distinct responses to lipopolysaccharide and exhibit differential expression of genes required for TLR4 signaling. , 2010, Cellular immunology.

[5]  Yu-cai Fu,et al.  Transcriptional regulation of increased CCL2 expression in pulmonary fibrosis involves nuclear factor-κB and activator protein-1. , 2013, The international journal of biochemistry & cell biology.

[6]  E. D. Bal de Kier Joffé,et al.  Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer , 2017, Journal of Cancer Research and Clinical Oncology.

[7]  Denis Thieffry,et al.  Logical Modeling and Dynamical Analysis of Cellular Networks , 2016, Front. Genet..

[8]  R. Ghosh,et al.  To be an ally or an adversary in bladder cancer: the NF-κB story has not unfolded. , 2015, Carcinogenesis.

[9]  William S. Hlavacek,et al.  Rule-based Modeling and Simulation of Biochemical Systems with Molecular Finite , 2010 .

[10]  H. Saji,et al.  Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  R. Lukaszewski,et al.  Targeting the “Cytokine Storm” for Therapeutic Benefit , 2013, Clinical and Vaccine Immunology.

[12]  E. Klipp,et al.  Mathematical modeling of intracellular signaling pathways , 2006, BMC Neuroscience.

[13]  F. Miller,et al.  Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. , 1992, Cancer research.

[14]  T. S. P. S.,et al.  GROWTH , 1924, Nature.

[15]  Joseph D Butner,et al.  Simulating cancer growth with multiscale agent-based modeling. , 2015, Seminars in cancer biology.

[16]  C. Gilles,et al.  EMT and inflammation: inseparable actors of cancer progression , 2017, Molecular oncology.

[17]  Kumaresan Ganesan,et al.  NFκB activation demarcates a subset of hepatocellular carcinoma patients for targeted therapy , 2016, Cellular Oncology.

[18]  G. Schulert,et al.  Macrophage activation syndrome and cytokine-directed therapies. , 2014, Best practice & research. Clinical rheumatology.

[19]  S. Chalmers,et al.  Growth, metastasis, and expression of CCL2 and CCL5 by murine mammary carcinomas are dependent upon Myd88. , 2012, Cellular immunology.

[20]  P. Allavena,et al.  Molecular pathways in cancer-related inflammation. , 2011, Biochemia medica.

[21]  Bo Cheng,et al.  Cellular mechanosensing of the biophysical microenvironment: A review of mathematical models of biophysical regulation of cell responses. , 2017, Physics of life reviews.

[22]  Q. Hu,et al.  Crosstalk between the HIF-1 and Toll-like receptor/nuclear factor-κB pathways in the oral squamous cell carcinoma microenvironment , 2016, Oncotarget.

[23]  D. Bray,et al.  Computer simulation of the phosphorylation cascade controlling bacterial chemotaxis. , 1993, Molecular biology of the cell.

[24]  C. Figdor,et al.  Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy , 2010, Cancer Immunology, Immunotherapy.

[25]  H. Kohrt,et al.  In situ vaccination for the treatment of cancer. , 2016, Immunotherapy.